SRPT
Sarepta Therapeutics Inc
18.70$
+1.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 78.8% | 79.0% | 76.4% | 78.4% | 74.6% | 77.6% | 70.2% | 72.2% | 77.9% | 75.8% | 72.7% | 69.7% | |
| 17.4% | 13.1% | 13.3% | 11.2% | 5.5% | 27.8% | 7.0% | 13.9% | 17.5% | 23.9% | 14.6% | 17.9% | |
| 55.7% | 51.3% | 43.1% | 42.7% | 33.3% | 34.2% | 15.1% | 21.7% | 24.4% | 28.1% | 20.5% | 24.7% | |
| 11.4% | 13.4% | 13.0% | 11.5% | 14.3% | 16.4% | 20.9% | 16.6% | 15.5% | 15.5% | 17.2% | 15.1% | |
| 7.8% | 9.9% | 11.6% | 14.2% | 15.7% | 18.9% | 27.2% | 27.0% | 30.8% | 27.3% | 31.5% | 28.4% | |
| 0.6% | 0.9% | 0.9% | 0.8% | 0.8% | 0.7% | 0.8% | 0.8% | 0.8% | 0.9% | 1.0% | 1.0% | |
| 75.4% | 73.7% | 70.2% | 68.5% | 66.1% | 61.5% | 67.0% | 63.1% | 62.2% | 65.9% | 52.7% | 52.1% | |
| 14.5% | 20.0% | 18.9% | 20.1% | 19.4% | 18.5% | 17.5% | 25.0% | 26.4% | 32.7% | 15.7% | 15.8% | |
| 10.4% | 3.8% | 3.3% | 2.7% | 2.5% | 0.3% | – | – | 0.3% | 0.3% | – | – | |
| 2.8% | 5.1% | 2.8% | 3.1% | 3.3% | 5.4% | 4.5% | 3.7% | 2.7% | 8.4% | 2.2% | 1.6% | |
| 39.8% | 34.7% | 35.2% | 33.1% | 31.6% | 28.7% | 32.8% | 31.0% | 29.6% | 24.7% | 26.4% | 26.6% | |
| 24.6% | 26.3% | 29.8% | 31.5% | 33.9% | 38.5% | 33.0% | 36.9% | 37.8% | 34.1% | 47.3% | 47.9% | |
| -144.4% | -136.2% | -136.8% | -128.6% | -121.4% | -106.3% | -134.4% | -121.2% | -132.9% | -145.6% | -143.0% | -142.7% | |
| 2.9% | 3.2% | 3.1% | 2.9% | 2.8% | 2.7% | 2.8% | 2.9% | 2.9% | 3.1% | 3.8% | 3.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.